Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 127.65 USD -0.07% Market Closed
Market Cap: 7.9B USD
Have any thoughts about
Jazz Pharmaceuticals PLC?
Write Note

Jazz Pharmaceuticals PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jazz Pharmaceuticals PLC
Operating Income Peer Comparison

Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Operating Income
$703.7m
CAGR 3-Years
24%
CAGR 5-Years
1%
CAGR 10-Years
14%
Perrigo Company PLC
NYSE:PRGO
Operating Income
$237.9m
CAGR 3-Years
-27%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Operating Income
-$98.8m
CAGR 3-Years
-15%
CAGR 5-Years
-25%
CAGR 10-Years
-7%
G
GH Research PLC
NASDAQ:GHRS
Operating Income
-$41.2m
CAGR 3-Years
-351%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Operating Income
€92.1m
CAGR 3-Years
179%
CAGR 5-Years
N/A
CAGR 10-Years
16%
Ovoca Bio PLC
LSE:OVB
Operating Income
-€4m
CAGR 3-Years
-5%
CAGR 5-Years
-11%
CAGR 10-Years
7%

See Also

What is Jazz Pharmaceuticals PLC's Operating Income?
Operating Income
703.7m USD

Based on the financial report for Sep 30, 2024, Jazz Pharmaceuticals PLC's Operating Income amounts to 703.7m USD.

What is Jazz Pharmaceuticals PLC's Operating Income growth rate?
Operating Income CAGR 10Y
14%

Over the last year, the Operating Income growth was 265%. The average annual Operating Income growth rates for Jazz Pharmaceuticals PLC have been 24% over the past three years , 1% over the past five years , and 14% over the past ten years .

Back to Top